Goldridge Terminal 로고 Goldridge Terminal
인기
로그인

관심목록에 추가
Pro 차트

Drugs Made In America Acq...

NasdaqGM: DMIIU · 실시간 가격 · USD
10.17
-0.01 (-0.10%)
종가 기준: Aug 12, 2026, 10:47 AM

Drugs Made In America Acquisition II Corp. (DMIIU) Stock Price, Analysis & Data

-0.10%
매수호가9.96
시가총액n/a
매출 (ttm)n/a
순이익 (ttm)8.58M
베타n/a
EPS (ttm)n/a
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)-36.32
P/S (ttm)n/a
Earnings Daten/a
매도호가10.12
거래량2,650
평균 거래량 (20일)546
시가10.17
전일 종가10.18
일중 범위10.17 - 10.20
52주 범위9.94 - 10.80
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

DMIIU 소개

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York...

[더 보기]
산업 Shell Companies
섹터 Financial Services
IPO 일자 Sep 25, 2025
직원 수 n/a
상장 거래소 NasdaqGM
티커 DMIIU
전체 기업 정보

재무 실적

2025년 Drugs Made In America Acquisition II의 매출은 0로, 전년 n/a 대비 undefined% 증가했습니다. 순이익은 4.19M로, undefined% 증가했습니다.

재무제표
news image

5개월 전 · Motley Fool

NexGen Energy’s Rook I Project Emerges as a Key Source in the Next Uranium Supply Wave

MMCAP International increased its stake in NexGen Energy during the fourth quarter, deepening exposure to the company’s Rook I uranium project in Canada. As governments extend reactor lifespans and re...

news image

8개월 전 · Simply Wall St.

Drugs Made In America Acquisition II Corp. (NASDAQ:DMII) is largely controlled by institutional shareholders who own 79% of the company

Key Insights Institutions' substantial holdings in Drugs Made In America Acquisition II implies that they have...